Last updated: March 26, 2026
Quick Answer: A Spitz nevus is a benign (noncancerous) mole, not melanoma — but it can look nearly identical to melanoma under the microscope, which makes it one of the most challenging skin lesions in dermatology. Most cases appear in children and young adults, require no treatment, and resolve on their own. However, any Spitz nevus that changes, bleeds, grows larger than 1 cm, or appears in an adult should be evaluated by a dermatologist promptly, because a small subset are atypical or malignant.
A Spitz nevus is a rare, benign skin growth made up of melanocytes — the same cells that produce melanin and, when they turn cancerous, cause melanoma. Because of this shared cell origin, Spitz nevi can mimic melanoma so closely that even experienced pathologists sometimes disagree on a diagnosis [2].
The lesion was first described by dermatopathologist Sophie Spitz in 1948, who called it a "juvenile melanoma" — a name that, while historically significant, caused enormous confusion because the lesion is not actually malignant.
Key characteristics of a classic Spitz nevus:
The confusion arises because the spectrum of Spitz lesions ranges from clearly benign to atypical (borderline) to outright malignant (Spitz melanoma). Knowing where a specific lesion falls on that spectrum is the central clinical challenge.
For context on how Spitz nevi fit within the broader universe of moles and pigmented lesions, see this overview of malignant and benign skin conditions and the detailed guide to benign moles explained.
Spitz nevi are most common in children and young adults, with the majority appearing before age 20 [1][3]. Children are significantly more likely to develop a Spitz nevus than adults, and the lesions in children are far more likely to be truly benign [3].
Who is most at risk:
Risk factors are not well-defined compared to conventional melanoma. Unlike typical melanoma, Spitz nevi are not strongly linked to sun exposure, family history, or fair skin — though these factors should still be considered in the broader clinical picture.
💡 Clinical note: When a Spitz-like lesion appears in an adult for the first time, the working assumption shifts toward "atypical" until proven otherwise. Age at presentation is one of the most important clinical variables.
This is the core question — and the honest answer is: it depends on a combination of clinical features, pathology findings, and molecular markers.
Distinguishing a Spitz nevus from melanoma is described in the medical literature as "particularly difficult," requiring a comprehensive approach that integrates clinical history, histopathological features, and molecular testing [2]. No single test is 100% reliable on its own.
1. Clinical and dermoscopic evaluation
Dermatologists first assess the lesion visually and with a dermoscope — a handheld magnifying device that reveals subsurface structures invisible to the naked eye [1]. Key dermoscopic patterns associated with benign Spitz nevi include:
Atypical or malignant patterns include asymmetric pigmentation, irregular streaks, regression structures, and blue-white veils — features also seen in melanoma.
Mole mapping (using a specialized camera with a dermatoscopic lens) is used to track changes in shape, size, and color over time [1]. This is especially useful for monitoring lesions in children where a watch-and-wait approach is chosen.
2. Histopathological examination (biopsy)
A skin biopsy is the only definitive way to know whether a lesion is cancerous [1]. The tissue sample is examined under a microscope by a pathologist who looks for:
Even with expert pathology, a subset of Spitz lesions fall into a gray zone called atypical Spitz tumors (AST) — lesions with some worrying features but not enough to definitively call them melanoma.
3. Molecular and immunohistochemical testing
When histopathology is inconclusive, molecular tools provide critical additional information [3]:
TestWhat It DetectsClinical UsePRAME IHCPRAME protein expressionElevated in Spitz melanoma; useful for distinguishing from benign/atypical Spitz [2]p16 IHCp16 protein lossAbsence strongly suggests atypical or malignant Spitz [2]FISH (Fluorescence in situ hybridization)Chromosomal copy number changesDetects gains/losses specific to melanomaCGH (Comparative genomic hybridization)Genome-wide chromosomal alterationsIdentifies melanoma-specific genetic patterns [3]PCRSpecific gene mutationsDetects BRAF, NRAS, HRAS mutations
Spitz melanomas typically express melanocytic markers including SOX10, S100, MITF, tyrosinase, and Melan A, while the absence of p16 staining is strongly suggestive of malignancy [2]. PRAME immunohistochemistry has emerged as particularly useful for separating Spitz melanomas from benign or atypical Spitz tumors [2].
For comparison, see how similar diagnostic challenges arise with dysplastic nevi and amelanotic melanoma — two other lesions that frequently require biopsy to rule out malignancy.
Most Spitz nevi in children are stable and harmless, but certain features should prompt an urgent dermatology visit rather than watchful waiting.
See a dermatologist promptly if the lesion:
The ABCDE rule applies here too:
⚠️ Common mistake: Assuming a pink bump in a child is "just a Spitz nevus" without professional evaluation. While most are benign, the diagnosis should always be confirmed by a dermatologist — not assumed based on appearance alone.
The right course of action depends on the patient's age, the lesion's characteristics, and the degree of diagnostic certainty.
Best for: Children with a small, symmetric, stable, classic-appearing Spitz nevus confirmed by a dermatologist.
Most children with a Spitz nevus do not require any treatment [1]. The standard approach involves:
This approach avoids unnecessary surgery while maintaining close oversight. Many Spitz nevi shrink and flatten on their own over several years, and some disappear entirely [1].
Best for: Lesions that are atypical, symptomatic, growing, or in adults where malignancy cannot be excluded.
Dermatologists recommend surgical removal when the Spitz nevus is [1]:
Excision is performed with a margin of normal surrounding skin to reduce the risk of recurrence. The removed tissue is sent for pathological analysis to confirm the diagnosis. If the pathology report returns as atypical or borderline, wider re-excision and possible sentinel lymph node biopsy may be discussed.
For those concerned about melanoma specifically, the melanoma surgery and treatment page outlines what happens when a lesion turns out to be malignant.
Best for: Any lesion where the diagnosis is uncertain after clinical and dermoscopic evaluation.
A shave or punch biopsy provides tissue for pathological analysis without committing to full excision. Based on the results:
Choose watchful waiting if: The patient is a child under 10, the lesion is small and symmetric, and a dermatologist has confirmed the classic clinical appearance with dermoscopy.
Choose excision if: The patient is an adult, the lesion is growing or symptomatic, or any atypical features are present on dermoscopy or biopsy.
Spitz nevi occupy a specific niche among pigmented skin lesions. Understanding how they compare to similar conditions helps clarify why they require specialized evaluation.
FeatureSpitz NevusDysplastic NevusCommon MoleMelanomaAge at onsetChildhood/young adultAny ageAny ageUsually adultMalignant potentialVery low (benign)Low-moderateVery lowMalignant by definitionBiopsy needed?Often yesSometimesRarelyYesSpontaneous resolutionCommonRareRareNoMolecular markersHRAS mutations commonBRAF mutationsVariesBRAF, NRAS, othersTreatmentMonitor or exciseMonitor or exciseUsually noneSurgery + staging
Related conditions worth understanding: dysplastic nevi (atypical moles), blue nevus, and atypical moles each have distinct features but share the common thread of requiring professional evaluation when they change or cause concern.
Whether a Spitz nevus is treated or monitored, long-term follow-up is essential. The goal is to catch any change early — before a benign lesion has any chance to evolve into something concerning.
Recommended monitoring schedule:
People with a history of Spitz nevi, especially atypical ones, may also benefit from a broader skin cancer screening given the shared diagnostic territory with melanoma. For those in the Toronto area, resources like finding a melanoma specialist near you can help connect patients with the right expertise.
Q: Is a Spitz nevus dangerous?
A classic Spitz nevus in a child is benign and not dangerous. The risk increases with atypical features, adult age at onset, or rapid growth. Any uncertain lesion should be biopsied to rule out Spitz melanoma.
Q: Can a Spitz nevus turn into melanoma?
True benign Spitz nevi do not transform into melanoma. However, what initially appears to be a Spitz nevus may turn out to be an atypical Spitz tumor or Spitz melanoma on biopsy — which is why professional evaluation matters.
Q: Does my child need surgery for a Spitz nevus?
Most children do not need surgery [1]. A dermatologist will recommend removal only if the lesion is growing, symptomatic, larger than 1 cm, or has irregular features. Watchful waiting with regular monitoring is the standard approach for stable, classic lesions.
Q: How is a Spitz nevus diagnosed?
Diagnosis involves clinical examination, dermoscopy, and usually a skin biopsy [1]. In ambiguous cases, immunohistochemistry (PRAME, p16) and molecular tests (FISH, CGH) are used to distinguish benign from malignant lesions [2][3].
Q: What does a Spitz nevus look like?
The classic form is a pink or red, smooth, dome-shaped bump, usually under 1 cm. A pigmented variant appears as a flat or slightly raised brown-to-black lesion. Both types can look similar to melanoma without specialized examination [1].
Q: How long does a Spitz nevus last?
Many Spitz nevi grow for a few months, then stabilize. Over several years, they often shrink and flatten, and some disappear completely without any treatment [1].
Q: What is an atypical Spitz tumor?
An atypical Spitz tumor (AST) is a borderline lesion with features that are more concerning than a benign Spitz nevus but do not fully meet the criteria for melanoma. These require wider excision and close follow-up, and molecular testing is often used to better characterize them [2][3].
Q: Should adults with a Spitz-like mole be worried?
Yes — adults who develop a new Spitz-like lesion should see a dermatologist promptly. Spitz-like lesions in adults carry a higher risk of being atypical or malignant compared to the same lesion in a child, and biopsy is generally recommended.
Q: Can dermoscopy alone diagnose a Spitz nevus?
Dermoscopy is a powerful screening tool but cannot definitively diagnose a Spitz nevus on its own. It guides the decision to biopsy and helps identify high-risk features, but tissue pathology remains the gold standard [1].
Q: What happens if the biopsy shows an atypical Spitz tumor?
The typical next step is wider surgical re-excision with clear margins. Depending on the degree of atypia and molecular findings, a sentinel lymph node biopsy may be discussed. Close dermatological follow-up is essential.
Spitz nevus — benign or melanoma? What to do comes down to this: most Spitz nevi are benign, especially in children, but the diagnostic overlap with melanoma is real and should never be dismissed. The stakes are too high to guess.
Here's what to do, step by step:
For children, reassurance is usually appropriate once a dermatologist has confirmed the diagnosis. For adults, the threshold for biopsy should be low. Either way, early evaluation by a qualified professional is the single most important step.
If you are in the Toronto or Greater Toronto Area and need an expert evaluation, The Minor Surgery Center offers specialized skin lesion assessment and removal services with board-certified surgeons experienced in pigmented skin lesions.
[1] 24439 Spitz Nevus - https://my.clevelandclinic.org/health/diseases/24439-spitz-nevus
[2] Jctp 2023 00023 - https://www.xiahepublishing.com/2771-165X/JCTP-2023-00023
[3] onlinelibrary.wiley - https://onlinelibrary.wiley.com/doi/10.1111/pde.13025
